Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice
- 9 December 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 52 (2), 347-358
- https://doi.org/10.1007/s00125-008-1215-5
Abstract
Aims/hypothesis Obesity and diabetes are associated with increased intracellular p38 mitogen-activated protein kinase (MAPK) signalling, which may promote tissue inflammation and injury. Activation of p38 MAPK can be induced by either of the immediate upstream kinases, MAP kinase kinase (MKK)3 or MKK6, and recent evidence suggests that MKK3 has non-redundant roles in the pathology attributed to p38 MAPK activation. Therefore, this study examined whether MKK3 signalling influences the development of obesity, type 2 diabetes and diabetic nephropathy. Methods Wild-type and Mkk3 (also known as Map2k3) gene-deficient db/db mice were assessed for the development of obesity, type 2 diabetes and renal injury from 8 to 32 weeks of age. Results Mkk3 +/+ db/db and Mkk3 −/− db/db mice developed comparable obesity and were similar in terms of incidence and severity of type 2 diabetes. At 32 weeks, diabetic Mkk3 +/+ db/db mice had increased kidney levels of phospho-p38 and MKK3 protein. In comparison, kidney levels of phospho-p38 in diabetic Mkk3 −/− db/db mice remained normal, despite a fourfold compensatory increase in MKK6 protein levels. The reduced levels of p38 MAPK signalling in the diabetic kidneys of Mkk3 −/− db/db mice was associated with protection against the following: declining renal function, increasing albuminuria, renal hypertrophy, podocyte loss, mesangial cell activation and glomerular fibrosis. Diabetic Mkk3 −/− db/db mice were also significantly protected from tubular injury and interstitial fibrosis, which was associated with reduced Ccl2 mRNA expression and interstitial macrophage accumulation. Conclusions/interpretation MKK3–p38 MAPK signalling is not required for the development of obesity or type 2 diabetes, but plays a distinct pathogenic role in the progression of diabetic nephropathy in db/db mice.This publication has 52 references indexed in Scilit:
- MKK3 signalling plays an essential role in leukocyte-mediated pancreatic injury in the multiple low-dose streptozotocin modelLaboratory Investigation, 2008
- p38MAP Kinase activity is required for human primary adipocyte differentiationFEBS Letters, 2007
- Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factorKidney International, 2007
- p38 Mitogen-activated Protein Kinase Plays an Inhibitory Role in Hepatic LipogenesisPublished by Elsevier BV ,2007
- Correlations of tissue macrophages and cytoskeletal protein expression with renal fibrosis in patients with diabetes mellitusClinical and Experimental Nephrology, 2006
- p38 Kinase-mediated Transactivation of the Epidermal Growth Factor Receptor Is Required for Dedifferentiation of Renal Epithelial Cells after Oxidant InjuryPublished by Elsevier BV ,2005
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- Role of mitogen-activated protein kinase in the regulation of transforming growth factor-?-induced fibronectin accumulation in cultured renal interstitial fibroblastsClinical and Experimental Nephrology, 2004
- p38α Mitogen-activated Protein Kinase Sensitizes Cells to Apoptosis Induced by Different StimuliMolecular Biology of the Cell, 2004
- Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cellsKidney International, 2003